Company profile: Quay Pharma
1.1 - Company Overview
Company description
- Provider of contract development, manufacturing and packaging services, with scientific expertise and flexible response to support projects and improve the chances of successful clinical trials. Independent and privately owned.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Quay Pharma
BioAgilytix
HQ: United States
Website
- Description: Provider of bioanalytical lab services specializing in immunoassays and cell-based assays, based in Research Triangle Park, NC. Offers custom assay development (de novo, partial, cross-matrix, GxP validations), method transfer, preclinical and clinical sample analysis, specimen collection kit support, off-the-shelf assays, and biomedical diagnostic testing for infectious diseases, diagnostic immunology, vitamin and parasite-borne infections, and LDTs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioAgilytix company profile →
Drug Delivery Experts
HQ: United States
Website
- Description: Provider of boutique drug product development services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Drug Delivery Experts company profile →
Amador Bioscience
HQ: United States
Website
- Description: Provider of translational sciences, clinical pharmacology, bioanalysis, biomarker, and clinical research services to biopharmaceutical companies to support drug development. Offerings include immunoassays and cell-based assays for biomarkers and anti-drug antibodies, biometrics and pharmacometrics, regulatory affairs, and support for global clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Amador Bioscience company profile →
Emergent Health
HQ: United States
Website
- Description: Provider of regenerative medicine, including nutraceuticals and phytonutritionals, developing and selling products such as Vita-Stim, a nutrient that enhances the immune system, nourishes stem cells, and maintains health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emergent Health company profile →
Toxikon
HQ: United States
Website
- Description: Provider of preclinical contract research services delivering medical device product development from concept to final product, including biocompatibility testing, microbiology and reusability validation, analytical chemistry, efficacy and surgical services, and consulting and risk assessment for regulatory compliance and market approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Toxikon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Quay Pharma
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Quay Pharma
2.2 - Growth funds investing in similar companies to Quay Pharma
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Quay Pharma
4.2 - Public trading comparable groups for Quay Pharma
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →